HemaSphere
(Jun 2022)
P352: SYMPTOMATIC VTE INCIDENCE IN ADULT ALL TREATED WITH PEG-ASPARAGINASE COMPARED TO THE NATIVE L-ASPARAGINASE IN WITH AN ASPARAGINASE-BASED PROTOCOL
R. Chen,
J. Seki,
L. Liu,
E. Atenafu,
K. Yee,
A. Schuh,
V. Gupta,
S. Chan,
A. Schimmer,
D. Maze,
M. Minden,
H. Sibai
Affiliations
R. Chen
1 University of Toronto, Toronto, Canada
J. Seki
1 University of Toronto, Toronto, Canada
L. Liu
1 University of Toronto, Toronto, Canada
E. Atenafu
1 University of Toronto, Toronto, Canada
K. Yee
1 University of Toronto, Toronto, Canada
A. Schuh
1 University of Toronto, Toronto, Canada
V. Gupta
1 University of Toronto, Toronto, Canada
S. Chan
1 University of Toronto, Toronto, Canada
A. Schimmer
1 University of Toronto, Toronto, Canada
D. Maze
1 University of Toronto, Toronto, Canada
M. Minden
1 University of Toronto, Toronto, Canada
H. Sibai
1 University of Toronto, Toronto, Canada
DOI
https://doi.org/10.1097/01.HS9.0000844296.82824.ea
Journal volume & issue
Vol. 6
pp.
252
– 253
WeChat QR code
Close